• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN 7.46% 72.0¢

ARGENICA THERAPEUTICS LIMITED

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN 20/05/24 13 3.3K
20/05/24 Last post  Digger59 Comments Created with Sketch.  13  Views Created with Sketch.  3.3K 
AGN 13/05/24 59 14K
13/05/24 Last post  Lefevre Comments Created with Sketch.  59  Views Created with Sketch.  14K 
AGN
AGN Media thread
2
13/05/24 82 25K
13/05/24 Last post  TradingHault Comments Created with Sketch.  82  Views Created with Sketch.  25K 
AGN 29/04/24 3 1.5K
29/04/24 Last post  TradingHault Comments Created with Sketch.  3  Views Created with Sketch.  1.5K 
AGN 24/04/24 1 580
24/04/24 Last post  TradingHault Comments Created with Sketch.  1  Views Created with Sketch.  580 
AGN 22/04/24 6 1.1K
22/04/24 Last post  daveg Comments Created with Sketch.  6  Views Created with Sketch.  1.1K 
AGN 22/04/24 0 188
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  188 
AGN
News: AGN Argenica Therapeutics Successfully Completes A$12.0M Placement
12/04/24 0 247
12/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  247 

See All Discussions arrow Created with Sketch.

Timeline

ARG-007 Reduces Effects of TBI in Preclinical Study
15 May 08:25
 
DSMB Confirms Safety of First Patients Dosed
29 Apr 09:02
 
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 08:47
 
Cleansing Notice
22 Apr 09:18
 
Application for quotation of securities - AGN
22 Apr 09:16
 
Proposed issue of securities - AGN
12 Apr 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
72.0¢
Change
0.050(7.46%)
Mkt cap ! $88.42M
Open High Low Value Volume
67.0¢ 72.0¢ 66.0¢ $392.2K 565.6K

Buyers (Bids)

No. Vol. Price($)
1 2500 68.0¢
 

Sellers (Offers)

Price($) Vol. No.
73.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 20/05/2024 (20 minute delay) ?
Last
72.0¢
  Change
0.050 ( 9.92 %)
Open High Low Volume
65.0¢ 72.0¢ 65.0¢ 94734
Last updated 15.58pm 20/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.